Venetoclax–obinutuzumab combinations are effective in fit patients with CLL
Crossref DOI link: https://doi.org/10.1038/s41571-023-00786-7
Published Online: 2023-05-26
Published Print: 2023-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2023-05-26
Version of Record valid from 2023-05-26
Article History
First Online: 26 May 2023